Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 87

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 16
Chunk 87
---
ITEM 16. FORM 10-K SUMMARY. 

None.

Schedule II—Condensed Financial Information of Registrant

 -144-

Elevance Health, Inc. (Parent Company Only)Balance Sheets(In millions, except share data)December 31,2024December 31,2023AssetsCurrent assets:Cash and cash equivalents$1,870 $1,483 Equity securities487 80 Other receivables49 58 Net due from subsidiaries4,697 — Other current assets705 959 Total current assets7,808 2,580 Other invested assets3,636 822 Property and equipment, net159 178 Deferred tax assets, net— 199 Investments in subsidiaries63,173 63,426 Other noncurrent assets584 217 Total assets$75,360 $67,422 Liabilities and shareholders’ equityLiabilitiesCurrent liabilities:Accounts payable and accrued expenses$737 $1,709 Net due to subsidiaries— 734 Current portion of long-term debt1,649 1,649 Other current liabilities610 413 Total current liabilities2,996 4,505 Long-term debt, less current portion29,193 23,221 Deferred tax liabilities, net55 — Other noncurrent liabilities1,801 390 Total liabilities34,045 28,116 Commitments and contingencies—Note 5Shareholders’ equityPreferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none— — Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 227,479,695 and 233,071,0882 2 Additional paid-in capital8,911 8,868 Retained earnings33,549 31,749 Accumulated other comprehensive loss(1,147)(1,313)Total shareholders’ equity41,315 39,306 Total liabilities and shareholders’ equity$75,360 $67,422  See accompanying notes.

 -145-

Elevance Health, Inc. (Parent Company Only)Statements of IncomeYears ended December 31(In millions)202420232022RevenuesNet investment income$110 $25 $4 Net (losses) gains on financial instruments(23)(100)2 Service fees9 8 7 Total revenues (losses